Replacement of animal serum proteins by human albumin for growth and interferon production by Namalva cells.

Antimicrobial Agents and Chemotherapy
A K FieldM R Hilleman

Abstract

Growth and interferon production by human lymphoblastoid cells (Namalva) have been achieved by using medium with a complete substitution of human albumin for fetal bovine serum. Medium containing 0.3% human albumin supported exponential cell growth (minimum doubling time, 20 h) in Bilthoven 10-liter fermentors. Interferon induction with Sendai virus resulted in interferon yields of 0.5 x 10(4) to 1.0 x 10(4) interferon units per 10(6) Namalva cells per ml in RPMI 1640 medium containing 0.15 to 0.3% human albumin. Both cell growth and interferon production in medium containing human albumin were comparable to growth and interferon production in the same medium containing 10 and 5% fetal bovine serum, respectively.

References

Jan 1, 1978·The Journal of General Virology·E A HavellJ Vilcek
Jan 1, 1975·Journal of Clinical Microbiology·H StranderK Cantell
Jan 1, 1979·The Journal of Infectious Diseases·J K Dunnick, G J Galasso
Mar 1, 1979·Antimicrobial Agents and Chemotherapy·F KleinP J Bridgen
Jul 1, 1979·The Journal of General Virology·K C ZoonM E Smith

❮ Previous
Next ❯

Citations

Nov 20, 2016·BioFactors·Dénes B HorváthyZsombor Lacza

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.